TD Asset Management Inc. raised its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 8.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,000 shares of the company’s stock after acquiring an additional 1,300 shares during the quarter. TD Asset Management Inc. owned approximately 0.13% of U.S. Physical Therapy worth $983,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. Pinebridge Investments L.P. increased its holdings in U.S. Physical Therapy by 1.0% during the 2nd quarter. Pinebridge Investments L.P. now owns 1,650 shares of the company’s stock valued at $100,000 after acquiring an additional 17 shares in the last quarter. Sei Investments Co. increased its holdings in U.S. Physical Therapy by 31.8% during the 2nd quarter. Sei Investments Co. now owns 2,576 shares of the company’s stock valued at $155,000 after acquiring an additional 622 shares in the last quarter. SG Americas Securities LLC purchased a new position in U.S. Physical Therapy during the 3rd quarter valued at about $170,000. Municipal Employees Retirement System of Michigan increased its holdings in U.S. Physical Therapy by 3.1% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 2,950 shares of the company’s stock valued at $178,000 after acquiring an additional 90 shares in the last quarter. Finally, BlueCrest Capital Management Ltd purchased a new position in U.S. Physical Therapy during the 2nd quarter valued at about $224,000. Hedge funds and other institutional investors own 99.75% of the company’s stock.

In related news, CFO Lawrance W. Mcafee sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $72.56, for a total value of $145,120.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Clayton Trier sold 4,250 shares of the business’s stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $71.97, for a total transaction of $305,872.50. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 29,250 shares of company stock valued at $1,986,645. 3.10% of the stock is owned by insiders.

A number of equities research analysts have recently commented on the stock. Barrington Research downgraded shares of U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a report on Friday, November 3rd. Zacks Investment Research downgraded shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Saturday, August 26th. BidaskClub upgraded shares of U.S. Physical Therapy from a “strong sell” rating to a “sell” rating in a report on Thursday, September 28th. Cantor Fitzgerald reiterated a “buy” rating and set a $74.00 price target on shares of U.S. Physical Therapy in a report on Thursday, November 2nd. Finally, Sidoti upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $62.00 to $74.00 in a report on Friday, September 8th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $69.00.

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) traded down $0.45 during midday trading on Thursday, hitting $72.00. 49,400 shares of the stock were exchanged, compared to its average volume of 57,235. The stock has a market capitalization of $911.51, a P/E ratio of 35.00, a PEG ratio of 3.11 and a beta of 1.08. U.S. Physical Therapy, Inc. has a 1-year low of $56.50 and a 1-year high of $78.00. The company has a current ratio of 2.04, a quick ratio of 2.04 and a debt-to-equity ratio of 0.30.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Thursday, November 2nd. The company reported $0.48 EPS for the quarter, missing analysts’ consensus estimates of $0.52 by ($0.04). The firm had revenue of $103.03 million for the quarter, compared to analysts’ expectations of $102.69 million. U.S. Physical Therapy had a return on equity of 13.37% and a net margin of 5.29%. analysts expect that U.S. Physical Therapy, Inc. will post 2.07 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Friday, December 8th. Investors of record on Friday, November 17th were issued a $0.20 dividend. The ex-dividend date was Thursday, November 16th. This represents a $0.80 dividend on an annualized basis and a yield of 1.11%. U.S. Physical Therapy’s payout ratio is 48.19%.

COPYRIGHT VIOLATION NOTICE: This piece of content was first published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/td-asset-management-inc-acquires-1300-shares-of-u-s-physical-therapy-inc-usph/1764045.html.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.